Is this you? As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.
Claim your profile
Articles by Oncoclínicas Group
Editorial: Immune checkpoint inhibitors in cancer: balancing the benefits with the side effects?
Immune checkpoint inhibitors (ICIs) have emerged as a revolutionary treatment for multiple solid and hematologic malignancies, associated with durable treatment responses (1, 2). ICIs enhance the immune response against cancer cells by binding to checkpoints that would normally induce immune suppression, thereby allowing for immune activation.
Discrepancies in breast cancer's oncological outcomes between public and private institution in Brazil southeast: a retrospective cohort study
Discrepancies in breast cancer's oncological outcomes between public and private institution in Brazil southeast: a retrospective cohort study Diocesio A. de Andrade1* , Ana C. Veneziani2 , Carlos E. Paiva3, Ricardo Reis3 , Carlos A. Filho1 , Andre O. Sanches4, Alison W. Barroso5 , Alessandra C. Paz6, Georgia C. Kons7, Daniel D. Preto3 , Maria C. Budib8, Maria A. Safro9, Gustavo S. Pinto10, João P. Bilibio11 and Cristiano D.
Management of Patients with Recurrent/Metastatic Endometrial Cancer: Consensus Recommendations from an Expert Panel from Brazil.
Diocesio A. de Andrade1, 2*, Andrea P. Gadelha1, 3, Andréia Melo1, 4, ANGELICA NOGUEIRA-RODRIGUES1, 5, Larissa M. Gomes1, 2, Mariana Scaranti1, 6, Joice M. Maia1, Alessandra M. Morelle1, 7, Candice Santos1, 8, Cristiano d. Souza1, 9, Daniela de Freitas1, 10, Donato Callegaro-Filho1, 11, Eduardo Paulino1, 4, Elge W. Júnior1, 2, Juliana M. Pimenta1, 12, Marcela B. dos Santos1, 2, Michelle Samora1, 13, Ronaldo P.
Cancer control in Latin America and the Caribbean: recent advances and opportunities to move forward
Summary The increasing burden of cancer represents a substantial problem for Latin America and the Caribbean. Two Lancet Oncology Commissions in 2013 and 2015 highlighted potential interventions that could advance cancer care in the region by overcoming existing challenges.
Genomic testing for targeted oncology drugs: hopes against hype.
Precision medicine entails access to genomic testing, including single gene assays and/or large next-generation sequencing (NGS) panels, in a given time point of the patient’s disease trajectory; data interpretation and reporting to physicians with acceptable turn-around times for straightforward decision making or case discussion; and access to drugs (preferably at the point-of-care) with approved therapies or clinical trial opportunities.
Efficacy of Dexrazoxane in Preventing Anthracycline Cardiotoxicity in Breast Cancer
JACC: CardioOncology Original Research Ariane V.S. Macedo, Ludhmila A. Hajjar, Alexander R. Lyon, Bruno R. Nascimento, Alessandro Putzu, Lorenzo Rossi, Rafael B. Costa, Giovanni Landoni, Angélica Nogueira-Rodrigues and Antonio L.P. Ribeiro Author + information Ariane V.S. Macedo, MD, MSca,b,∗ (arianevsm{at}yahoo.com.br), @md_arianemacedo, Ludhmila A. Hajjar, MD, PhDc, Alexander R. Lyon, MDd, Bruno R. Nascimento, MD, PhDa, Alessandro Putzu, MDe, Lorenzo Rossi, MDf, Rafael B.
Show More
loading
Actions
Is this you?
As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.Get in touch with Oncoclínicas
Contact Oncoclínicas, search articles and posts on X, monitor coverage, and track replies from one place.
Learn more about Muck Rack